Stability test of novel combined formulated dry powder inhalation system containing antibiotic: physical characterization and in vitro–in silico lung deposition results-Reference-Cited by-同舟云学术

Stability test of novel combined formulated dry powder inhalation system containing antibiotic: physical characterization and in vitro–in silico lung deposition results

Published:2019-06-04 Issue:8 Volume:45 Page:1369-1378
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Benke Edit¹,Farkas Árpád²,Balásházy Imre²,Szabó-Révész Piroska¹,Ambrus Rita¹

Affiliation:

1. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged, Hungary;

2. Centre for Energy Research, Hungarian Academy of Sciences, Budapest, Hungary

Funder

UNKP-18-3 New National Excellence Program of the Ministry of Human Capacities

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://tandfonline.com/doi/pdf/10.1080/03639045.2019.1620268

Reference57 articles.

1. Cystic fibrosis: symptoms, causes, and management Med News Today [Internet]. 2018 [cited 2018 Jul 2]. Available from: https://www.medicalnewstoday.com/articles/147960.php

2. Cystic Fibrosis

3. Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies

4. Native Small Airways Secrete Bicarbonate

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Physico-Chemical Stability and Aerodynamic Properties of Novel “Nano-in-Micro” Structured Dry Powder Inhaler System;Micromachines;2023-06-30

2. Dry Powder Inhalers Based on Chitosan-Mannitol Binary Carriers: Effect of the Powder Properties on the Aerosolization Performance;AAPS PharmSciTech;2022-06-14

3. Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach;Drug Delivery and Translational Research;2022-03-14

4. Developing ciprofloxacin dry powder for inhalation: A story of challenges and rational design in the treatment of cystic fibrosis lung infection;International Journal of Pharmaceutics;2022-02

5. Evaluation of the Mucoadhesive Properties of Chitosan-Based Microstructured Lipid Carrier (CH-MLC);Pharmaceutics;2022-01-12